BXP Picks Up Kendall Mid-Rise for $602M
One of Kendall Square's dominant players just added a new property to its portfolio as troubled life-science firm Biogen exits a major lease nearby.
One of Kendall Square's dominant players just added a new property to its portfolio as troubled life-science firm Biogen exits a major lease nearby.